FDA’s Changes in Vaping Product Enforcement

Senior officials in the FDA’s tobacco center recently faced unexpected changes as new guidelines allow more unauthorized electronic cigarettes and nicotine pouches in the U.S. market. This development, disclosed shortly before former FDA Commissioner Marty Makary’s resignation, lets companies introduce certain nicotine products without full regulatory approval.

The unexpected release of the guidelines caught some FDA officials off guard, sparking confusion about their origins and authorization. According to anonymous staff, high-level meetings are ongoing to address how to implement a memo that contradicts longstanding policies requiring scientific validation of health benefits for new products.

Mitch Zeller, former FDA tobacco director, raised concerns about whether key experts had opposed the policy yet were overridden. The guidelines bypass a mandatory public comment period, being formalized after news of Makary’s planned firing. Despite industry lobbying efforts, the FDA’s changes aim to control youth nicotine addiction while promoting adult alternatives to smoking.

Most health researchers agree e-cigarettes are less harmful than traditional cigarettes, promoted in the U.K. as a smoking alternative.

While U.S. researchers acknowledge harm reduction, the FDA historically struggled with regulation, having approved products from five companies but rejected millions due to flavors appealing to youth. Unauthorized vapes remain widespread despite recent state and federal restrictions.

Under the new policy, the FDA plans to list e-cigarettes and pouches for “enforcement discretion,” allowing sales without removal threats. Though no public list exists, it’s expected to permit new flavors previously blocked.

Brian King, former FDA tobacco director, noted the agency’s increased receptivity to flavored products. Illegal flavored vapes, including mango and strawberry, have replaced Juul’s products in U.S. stores. Juul now considers competing with disposable Chinese vapes dominating U.S. sales.

Robyn Gougelet, a Juul VP, stated regulating and responsibly marketing products is preferable to illegal and untested imports.

The FDA’s enforcement will focus on vapes with youth-appealing features, not flavors, acknowledging the surge of illegal products crossing borders. Jonathan Foulds of Penn State University said the agency plans to target major offenders.

The impact of the FDA’s approach remains uncertain within the vaping industry, comprising large tobacco firms and small companies selling imports. The guidelines suggest only e-cigarettes undergoing “scientific review” may launch without authorization, benefiting larger firms with resources for detailed health data, noted King.

Small company lobbyists worry about policy outcomes and possible exclusion from the marketplace. Tony Abboud of the Vapor Technology Association highlighted potential benefits for big companies if smaller competitors are hindered.